Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Entrinsic Health

Entrinsic Health
2012 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
9 INVESTORS
Description

Developer of dietary supplements designed to address critical digestive health problems in humans and animals around the world. The company's supplements provide amino acids and electrolytes that help to manage gastrointestinal (GI) dysfunction that occurs from the treatment of cancer, by rebuilding and protecting the gastrointestinal tract delivering total body hydration, enabling patients to get relief from the side effects caused by chemotherapy or radiation therapy.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 100 River Ridge Drive
  • Suite 206
  • Norwood, MA 02062
  • United States

+1 (781) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Entrinsic Health’s full profile, request a free trial.

Entrinsic Health Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 000.00 Completed Clinical Trials - Phase 2
6. Later Stage VC 28-Aug-2018 000.00 000.00 Completed Clinical Trials - Phase 2
5. Accelerator/Incubator 000.00 Completed Startup
4. Grant 17-May-2016 000.00 Completed Startup
3. Early Stage VC (Series B) 04-Mar-2016 00.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 31-Jan-2015 $5.12M $5.12M 000.00 Completed Startup
1. Grant 01-Jan-2015 $500K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Entrinsic Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Entrinsic Health Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Space Biomedical Research Institute Government 000 0000 000000 0
Johnson & Johnson Corporation Minority 000 0000 000000 0
Junonia Capital, LLC Venture Capital Minority 000 0000 000000 0
SmartCap Venture Capital Minority 000 0000 000000 0
Enterade Investment Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Entrinsic Health Executive Team (10)

Name Title Board
Seat
Contact
Info
Stephen Gatto Chairman & Chief Executive Officer
Daniel Dennison Ph.D Board Member, Advisory Board Member & Chief Technology Officer
Sadasivan Vidyasagar Ph.D Scientific Co-founder, Chief Scientific Officer & Board Member
Paul Okunieff MD Scientific Co-Founder & Chief Medical Officer
Charles Fuchs MD Advisory Board Member

1 Former Executive

You’re viewing 5 of 10 executives. Get the full list »

Entrinsic Health Board Members (11)

Name Representing Role Since Contact
Info
Brian Fox Entrinsic Health Board Member 000 0000
Byron Kalogerou JD McDermott Will & Emery Board Member 000 0000
Charlie Raffin Entrinsic Health Board Observer 000 0000
Daniel Dennison Ph.D Entrinsic Health Board Member, Advisory Board Member & Chief Technology Officer 000 0000
Jane Teague Florida Institute for the Commercialization of Public Research Board Observer 000 0000

1 Former Board Member

You’re viewing 5 of 11 board members. Get the full list »